Wimps... the bloody lot of you. All here for a bit of collective hand-wringing.
The important number is the growth in customers... which this announcement doesn't offer and which we won't see until the next 4C.
The company has clearly flagged they are putting the marketing effort into partnerships, which is going to mean a slowing in the growth rate of ARR but [hopefully] an increase in customer acquisition.
- Forums
- ASX - By Stock
- LVT
- Ann: Q1 ARR $42.9m, confirms strong outlook
Ann: Q1 ARR $42.9m, confirms strong outlook, page-58
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online